Daniel J. Verdon

695 total citations
15 papers, 473 citations indexed

About

Daniel J. Verdon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Daniel J. Verdon has authored 15 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Daniel J. Verdon's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Daniel J. Verdon is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Daniel J. Verdon collaborates with scholars based in New Zealand, Australia and United States. Daniel J. Verdon's co-authors include P. Rod Dunbar, Anna E. S. Brooks, Misty R. Jenkins, Anh H. Nguyen, Anuj Gaggar, G. Mani Subramanian, Christian Schwabe, Edward Gane, Matthias Mulazzani and Margaret A. Brimble and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Daniel J. Verdon

14 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel J. Verdon New Zealand	11	196	164	154	140	103	15	473
Guoxin Liang China	10	204 1.0×	137 0.8×	129 0.8×	69 0.5×	159 1.5×	19	476
Shanshan Lin China	14	172 0.9×	88 0.5×	128 0.8×	102 0.7×	238 2.3×	25	561
Tsubasa Munakata Japan	11	241 1.2×	71 0.4×	195 1.3×	72 0.5×	368 3.6×	16	639
Baharak Khadang Italy	10	115 0.6×	83 0.5×	29 0.2×	132 0.9×	210 2.0×	13	474
Takahiro Ohtsuki Japan	11	91 0.5×	85 0.5×	67 0.4×	30 0.2×	157 1.5×	18	372
Michael Warlich Germany	4	239 1.2×	31 0.2×	206 1.3×	43 0.3×	101 1.0×	4	377
Shuxia Song China	12	91 0.5×	140 0.9×	38 0.2×	126 0.9×	140 1.4×	24	422
Qunfeng Wu United States	12	73 0.4×	79 0.5×	61 0.4×	49 0.3×	232 2.3×	19	403
Rachael Kenworthy United States	7	86 0.4×	46 0.3×	119 0.8×	41 0.3×	196 1.9×	7	332
Zhunyi Xie China	11	66 0.3×	347 2.1×	29 0.2×	102 0.7×	98 1.0×	14	494

Countries citing papers authored by Daniel J. Verdon

Since Specialization

Citations

This map shows the geographic impact of Daniel J. Verdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Verdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Verdon more than expected).

Fields of papers citing papers by Daniel J. Verdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Verdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Verdon. The network helps show where Daniel J. Verdon may publish in the future.

Co-authorship network of co-authors of Daniel J. Verdon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Verdon. A scholar is included among the top collaborators of Daniel J. Verdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Verdon. Daniel J. Verdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Verdon, Daniel J., Deborah W. Knapp, Yale S. Michaels, et al.. (2025). Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa. Molecular Therapy — Nucleic Acids. 36(1). 102472–102472.

Verdon, Daniel J., et al.. (2024). Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic LAMB3 Variant for Junctional Epidermolysis Bullosa. SHILAP Revista de lepidopterología. 5(3). 100343–100343. 1 indexed citations

Chen, Chun‐Jen J., Daniel J. Verdon, Anna E. S. Brooks, et al.. (2024). Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors. Frontiers in Immunology. 15. 1412076–1412076. 2 indexed citations

Verdon, Daniel J. & Misty R. Jenkins. (2021). Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy. Cancers. 13(16). 4245–4245. 19 indexed citations

Verdon, Daniel J., Katherine A. Watson, Matthias Mulazzani, et al.. (2021). Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma. Clinical & Translational Immunology. 10(5). e1283–e1283. 29 indexed citations

Verdon, Daniel J., Matthias Mulazzani, & Misty R. Jenkins. (2020). Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion. International Journal of Molecular Sciences. 21(19). 7357–7357. 55 indexed citations

Gane, Edward, Daniel J. Verdon, Anna E. S. Brooks, et al.. (2019). Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. Journal of Hepatology. 71(5). 900–907. 223 indexed citations

Williams, Geoffrey M., et al.. (2019). Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines. Journal of Medicinal Chemistry. 63(5). 2282–2291. 27 indexed citations

Lorenz, Natalie, Daniel J. Verdon, Martin Middleditch, et al.. (2016). Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21. Immunology and Cell Biology. 94(10). 955–963. 31 indexed citations

10.

Lorenz, Natalie, Daniel J. Verdon, Chun‐Jen J. Chen, et al.. (2015). Human T cell activation induces synaptic translocation and alters expression of the serine protease inhibitor neuroserpin and its target protease. Journal of Leukocyte Biology. 97(4). 699–710. 14 indexed citations

11.

Brimble, Margaret A., Clive W. Evans, Daniel J. Verdon, et al.. (2015). Cell-targeted platinum nanoparticles and nanoparticle clusters. Organic & Biomolecular Chemistry. 13(23). 6567–6572. 14 indexed citations

12.

Sheppard, Hilary M., Daniel J. Verdon, Anna E. S. Brooks, et al.. (2014). MicroRNA regulation in human CD8+ T cell subsets – cytokine exposure alone drives miR-146a expression. Journal of Translational Medicine. 12(1). 292–292. 18 indexed citations

13.

Sheppard, Hilary M., et al.. (2013). Recombinant Adeno-Associated Virus Serotype 6 Efficiently Transduces Primary Human Melanocytes. PLoS ONE. 8(4). e62753–e62753. 3 indexed citations

14.

Wang, Carol, et al.. (2011). Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells. Virology Journal. 8(1). 551–551. 18 indexed citations

15.

Lai, Angela, et al.. (2007). The distribution of the growth factors FGF-2 and VEGF, and their receptors, in growing red deer antler. Tissue and Cell. 39(1). 35–46. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact